Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis

This publication has 18 references indexed in Scilit:

• Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?
  Journal of Clinical Oncology, 1992
• The Importance of Prognostic Factors in the Individual Treatment of Patients with Disseminated Germ Cell Tumours
  British Journal of Urology, 1990
• Excision of residual masses after platinum based chemotherapy for non-seminomatous germ cell tumours
  European Journal of Cancer and Clinical Oncology, 1989
• Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin.
  Journal of Clinical Oncology, 1989
• The role of surgery in metastatic testicular germ cell tumours (GCT)
  British Journal of Cancer, 1989
• Prognostic factors for relapse after complete response in patients with metastatic germ cell tumors
  Cancer, 1989
• Testicular Cancer
  Acta Oncologica, 1988
• Non-seminomatous germ cell testicular tumours: Residual masses after chemotherapy
  British Journal of Surgery, 1985
• Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma
  British Journal of Cancer, 1984
• Evaluation of survival data and two new rank order statistics arising in its consideration.
  1966